» Articles » PMID: 11997315

Hyperuricemia Induces a Primary Renal Arteriolopathy in Rats by a Blood Pressure-independent Mechanism

Overview
Specialties Nephrology
Physiology
Date 2002 May 9
PMID 11997315
Citations 278
Authors
Affiliations
Soon will be listed here.
Abstract

Hyperuricemia is associated with hypertension and vascular disease, but whether this represents a causal relationship or an epiphenomenon remains unknown. We recently reported a model of mild hyperuricemia in rats that results in increased blood pressure and mild renal fibrosis. In this study, we examined the effect of hyperuricemia on the renal vasculature. Rats fed 2% oxonic acid and a low-salt diet for 7 wk developed mild hyperuricemia (1.8 vs. 1.4 mg/dl, P < 0.05), hypertension [147 vs. 127 mmHg systolic blood pressure (SBP), P < 0.05], and afferent arteriolar thickening, with a 35% increase in medial area (P < 0.05). Allopurinol or benziodarone prevented the hyperuricemia, hypertension, and arteriolopathy. Hydrochlorothiazide treatment did not prevent the hyperuricemia or arteriolopathy despite controlling blood pressure. In contrast, the arteriolopathy and hypertension were prevented by both enalapril and losartan. Uric acid also directly stimulated vascular smooth muscle cell proliferation in vitro, and this was partially inhibited by losartan. Thus hyperuricemia induces a renal arteriolopathy in rats that is blood pressure independent and involves the renin-angiotensin system.

Citing Articles

The impact of uric acid on musculoskeletal diseases: clinical associations and underlying mechanisms.

Zhang J, Sun N, Zhang W, Yue W, Qu X, Li Z Front Endocrinol (Lausanne). 2025; 16:1515176.

PMID: 39968300 PMC: 11832375. DOI: 10.3389/fendo.2025.1515176.


Impact of Hyperuricemia on Clinical Outcomes in Sepsis Patients: A Retrospective Cohort Study.

Alshehri A, Alrashed M, Shawaqfeh M, Almutairi F, Alanazi A, Alfaifi M J Clin Med. 2024; 13(21).

PMID: 39518687 PMC: 11546594. DOI: 10.3390/jcm13216548.


Heterogeneous afferent arteriolopathy: a key concept for understanding blood pressure-dependent renal damage.

Kohagura K, Zamami R, Oshiro N, Shinzato Y, Uesugi N Hypertens Res. 2024; 47(12):3383-3396.

PMID: 39379463 PMC: 11618077. DOI: 10.1038/s41440-024-01916-z.


Hyperuricemia and associated factors among hypertensive patients attending an academic hospital of Ethiopia: A cross-sectional study.

Philmon Daka O, Bekele Jember T, Hunie Tesfa K Metabol Open. 2024; 23:100312.

PMID: 39282241 PMC: 11393599. DOI: 10.1016/j.metop.2024.100312.


Impact of hyperuricemia on CKD risk beyond genetic predisposition in a population-based cohort study.

Kim Y, Jo J, Ji Y, Bae E, Lee K, Paek J Sci Rep. 2024; 14(1):18466.

PMID: 39122851 PMC: 11316130. DOI: 10.1038/s41598-024-69420-5.